S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.83 (-14.43%)
BABA   182.68 (+0.11%)
GE   11.29 (+0.00%)
T   38.96 (-0.51%)
F   8.81 (+0.00%)
BAC   32.75 (-0.12%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.83 (-14.43%)
BABA   182.68 (+0.11%)
GE   11.29 (+0.00%)
T   38.96 (-0.51%)
F   8.81 (+0.00%)
BAC   32.75 (-0.12%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.83 (-14.43%)
BABA   182.68 (+0.11%)
GE   11.29 (+0.00%)
T   38.96 (-0.51%)
F   8.81 (+0.00%)
BAC   32.75 (-0.12%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.83 (-14.43%)
BABA   182.68 (+0.11%)
GE   11.29 (+0.00%)
T   38.96 (-0.51%)
F   8.81 (+0.00%)
BAC   32.75 (-0.12%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 C4X DiscoveryMidatech PharmaPharmaustQuest PharmaTechKazia Therapeutics
SymbolLON:C4XDLON:MTPHASX:PAACVE:QPTASX:KZA
Price Information
Current PriceGBX 15.50GBX 3.45A$0.12C$0.13A$0.41
52 Week RangeN/AN/AN/AN/AN/A
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap£9.83 million£16.21 million$29.28 millionC$20.09 million$24.87 million
BetaN/AN/AN/AN/AN/A
Average Volume2,98361,863N/A28,669N/A
Sales & Book Value
Annual Revenue£7.06 million£1.84 million$4.35 millionC$38,871.00$1.54 million
Price / Sales1.288.817.98538.2816.55
CashflowGBX 14.50 per shareGBX 2.08 per shareA$0.01 per shareC$0.01 per shareA$0.09 per share
Price / Cash1.071.6615.719.674.60
Book ValueGBX 22.20 per shareGBX 6 per shareA$0.03 per shareC($0.07) per shareA$0.23 per share
Price / Book0.010.014.26-1.711.80
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (5)GBX (4.40)A($0.01)C($0.03)A($0.18)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A4.42%4.35%N/AN/A
Current Ratio9.78%4.21%3.28%0.25%3.95%
Quick Ratio9.78%3.83%2.59%0.19%3.68%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees4773N/AN/AN/A
Shares Outstanding58.48 million469.90 million301.82 million167.39 million62.17 million
Next Earnings DateN/AN/AN/A12/18/2019 (Estimated)N/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
 C4X DiscoveryMidatech PharmaPharmaustQuest PharmaTechKazia Therapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel